Bronchial Spasm clinical trials

The registry lists 44 studies for Bronchial Spasm across more than 10 countries. 4 are recruiting or about to start. 10 of them are mainly about Bronchial Spasm (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.

Get an email when these change. Save the Bronchial Spasm studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 35
Recruiting: 3
Terminated: 2
Status unknown: 2
Active, not recruiting: 1
Not yet recruiting: 1

Phase

Phase 3: 7
Phase 2: 7
Phase 4: 5
Phase 1: 2

Where

United States: 16
Italy: 6
Germany: 4
Spain: 3
Brazil: 3
Turkey: 3

Who runs them

GlaxoSmithKline (6) · Amphastar Pharmaceuticals, Inc. (4) · AstraZeneca (2) · Wuerzburg University Hospital (2) · European Society of Anaesthesiology (2) · Bezmialem Vakif University (2) · Ospedale San Raffaele (2) · Tampere University (1)

What is being tested here

Drugs under test in Bronchial Spasm studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Fluticasone	0	2
Salmeterol Xinafoate	0	2
Lidocaine	0	1
Ketamine	1	1
Omalizumab	0	1
Beclomethasone	0	1
Senicapoc	0	1
Albuterol	1	1

Drug classes tested here Corticosteroids 3 · Bronchodilators 3

Coming up

1phase 3 study under way

2studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2, phase 3 first

Dec 2026A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a) · Phase 3 · GlaxoSmithKline
May 2027Perioperative Respiratory Adverse Events in Cleft Lip and Palate Surgery: Incidence, Risk Factors, and Clinical Scoring · Marmara University Pendik Training and Research Hospital

Who these studies take

Of the 3 Bronchial Spasm studies recruiting now, 2 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	0 (0%)	0 (0%)
18	3 (100%)	3 (100%)
30	3 (100%)	3 (100%)
40	3 (100%)	3 (100%)
50	3 (100%)	3 (100%)
65	3 (100%)	3 (100%)
75	3 (100%)	3 (100%)
85	2 (67%)	2 (67%)

Across all 44 studies, recruiting or not: 57% stop at 75 or younger and 48% at 65; 48% take children; 2% are for women only and 2% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 44 of 44. search them.